Sunday, August 24, 2025

Latest

Paypal: Consensus Price Target Jumps To $314 Following Q1 Results

Paypal Holdings (NASDAQ: PYPL) ended last week down almost 5% following the release of its financial results on Wednesday wherein its first quarter results came in above analysts’ expectations. The company announced its first revenue of $6.03 billion, and a gross margin of 49.2%. Net Income for the quarter was $1.09 billion, or an 18.2% net margin, and earnings per share of $0.92.

A number of analysts changed their price targets off the back of Paypal’s earnings, bringing their average 12-month price target slightly higher from $310.52 to $314.25 from a total of 49 analysts who cover the name.

Below are the most recent analyst changes as of the time writing:

  • Oppenheimer raises target price to $322 from $310
  • Credit Suisse raises target price to $315 from $310
  • JP Morgan raises target price to $313 from $310
  • Evercore ISI raises price target to $313 from $312
  • Cowen and Company raises target price to $309 from $300
  • RBC raises target price to $300 from $292
  • Truist Securities cuts target price to $275 from $285
  • Rosenblatt Securities raises target price to $354 from $350
  • Compass Point raises target price to $290 from $280
  • Morgan Stanley raises price target to $337 from $329
  • Raymond James raises target price to $345 from $333
  • BMO raises target price to $256 from $241

In BMO’s note to investors, their analyst, James Fotheringham, reiterates his market perform rating and raises their 12-month price target to $256 from $241. BMO also slightly changes their 2021 and 2022 earnings per share and net revenue estimates, saying, “following PYPL’s 1Q21 broad-based beat and encouraging guidance, we raise our estimates by up to 2% (higher revenues and lower costs).”

Paypal broadly beat all BMO’s estimates for the first quarter with core earnings per share coming in at $1.07 versus their $1.02 estimate, while Paypal raised their guidance during the earnings call. Paypal now expects 2021 TPV growth to be +30% year over year, net revenues to be $25.75 billion, operating margin +100bps, and free cash flow to come in at $6 billion.

Fotheringham says that Paypal had an “impressive operating performance,” with volume-driven cost growth only equating to 33% of the rate of revenue growth. He writes, “Core volume and NNA growth exceeded our expectations, implying that pandemic-inspired e-commerce trends are not abating yet. New product initiatives remain on a fast-track (e.g., Venmo credit card, in-store QR codes, BNPL, crypto trading), and the financial super-app will roll-out in 3Q21E, which we expect will accelerate growth even further (via higher engagement and product cross-selling).”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Sandstorm Gold Fades Into Royal Gold Merger

Equinox Gold Q2 Earnings: Back On Track

G Mining Q2 Earnings: Costing Gone Wild

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

BMO Lowers Take-Two Interactive’s Price Target By $75 Following Continuous Delays

Last week Take-Two Interactive (NASDAQ: TTWO) announced that they reiterated their 2022 guidance and outlook....

Wednesday, September 29, 2021, 03:48:00 PM

BMO Expects Miners To Be Hit With Cost Inflation Headwinds In Q1 Results

On April 18, BMO released their first quarter preview on their metals and mining coverage,...

Thursday, April 21, 2022, 11:28:00 AM

Tilray: Haywood Expects Canadian Market Share To Drop In First Quarter

Tilray Inc (TSX: TLRY) (NASDAQ: TLRY) announced that they would be reporting their Fiscal first-quarter...

Thursday, September 30, 2021, 10:38:00 AM

Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target

Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is...

Sunday, June 13, 2021, 01:08:00 PM

Antibe: Canaccord Lowers Price Target After Co-Leading $40.4 Million Financing

Wednesday, Antibe Therapeutics (TSX: ATE) announced that they closed their bought deal financing. The bought...

Friday, February 26, 2021, 11:55:00 AM